These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4239752)

  • 1. Comparison of human plasmins formed by activation with trace and large amounts of streptokinase.
    Muramatu M; Hayakumo Y; Onishi T; Sato T; Fujii S
    J Biochem; 1969 Mar; 65(3):329-42. PubMed ID: 4239752
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of formation of bovine plasminogen activator from human plasmin.
    Ling CM; Summaria L; Robbins KC
    J Biol Chem; 1965 Nov; 240(11):4213-8. PubMed ID: 4221202
    [No Abstract]   [Full Text] [Related]  

  • 3. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
    GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS
    Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation and characterization of bovine plasminogen activator from a human plasminogen-streptokinase mixture.
    Ling CM; Summaria L; Robbins KC
    J Biol Chem; 1967 Apr; 242(7):1419-25. PubMed ID: 4960668
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
    Toki N; Takasugi S; Sumi H; Yamura T
    Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor.
    Abiko Y; Iwamoto M; Tomikawa M
    Biochim Biophys Acta; 1969; 185(2):424-31. PubMed ID: 4241289
    [No Abstract]   [Full Text] [Related]  

  • 8. The active site of bovine plasminogen activator. Interaction of streptokinase with human plasminogen and plasmin.
    Summaria L; Ling CM; Groskopf WR; Robbins KC
    J Biol Chem; 1968 Jan; 243(1):144-50. PubMed ID: 4229831
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of the binding of antifibrinolytic amino acids to various plasminogens.
    Brockway WJ; Castellino FJ
    Arch Biochem Biophys; 1972 Jul; 151(1):194-9. PubMed ID: 5044515
    [No Abstract]   [Full Text] [Related]  

  • 11. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of guanidine compounds on the activation of human plasminogen by streptokinase and on the rates of hydrolysis of p-toluenesulfonyl-L-arginine methyl ester by plasmin and activator.
    Roberts PS; Burkat RK
    Biochim Biophys Acta; 1966 Jun; 118(3):592-603. PubMed ID: 4226322
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of streptokinase and human plasminogen. VI. Function of the streptokinase moiety in the activator complex.
    Buck FF; Boggiano E
    J Biol Chem; 1971 Apr; 246(7):2091-6. PubMed ID: 4252219
    [No Abstract]   [Full Text] [Related]  

  • 14. THE STREPTOKINASE ACTIVATION OF HUMAN PLASMINOGEN. DIRECT ANALYSIS OF THE ACTIVATION MIXTURE.
    RIFE U; SHULMAN S
    Thromb Diath Haemorrh; 1963 Nov; 10():133-45. PubMed ID: 14081275
    [No Abstract]   [Full Text] [Related]  

  • 15. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 16. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 17. THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES.
    ANDERSON AJ
    Biochem J; 1963 Sep; 88(3):460-9. PubMed ID: 14071519
    [No Abstract]   [Full Text] [Related]  

  • 18. Anion-specific effects on the streptokinase activation of human plasminogen.
    Gajewski J; Markus G
    J Biol Chem; 1968 Dec; 243(23):6210-5. PubMed ID: 4235516
    [No Abstract]   [Full Text] [Related]  

  • 19. PURIFICATION OF STREPTOKINASE AND HUMAN PLASMIN AND THEIR INTERACTION.
    BLATT WF; SEGAL H; GRAY JL
    Thromb Diath Haemorrh; 1964 Jul; 11():393-403. PubMed ID: 14191720
    [No Abstract]   [Full Text] [Related]  

  • 20. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.